Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment

Harekrishna Roy1, Asha Gummadi1, Bhabani Shankar Nayak2

  • 1Department of Pharmaceutics, Nirmala College of Pharmacy, Mangalagiri, Guntur, Affiliated to Acharya Nagarjuna University, Andhra Pradesh, 522503, India.

Abstract

Insights

This study explores key structural proteins of SARS-CoV-2, including nucleocapsid (N), membrane (M), envelope (E), and spike (S) proteins, to understand COVID-19 transmission and treatment. Further research into viral genomics and host cell invasion is crucial for recovery.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has created a global health crisis.
  • Understanding the virus's structure and function is critical for developing effective treatments.

Purpose of the Study:

  • To analyze the structural proteins of SARS-CoV-2: nucleocapsid (N), membrane (M), envelope (E), and spike (S).
  • To explore potential therapeutic targets and understand viral transmission mechanisms.

Main Methods:

  • Structure-based drug design.
  • Crystallographic studies to determine protein topology.

Main Results:

  • N-protein facilitates viral genome processing and localization.
  • M protein influences virion shape and stabilization with the Golgi-endoplasmic reticulum.
  • E protein is involved in viral morphogenesis and pathogenesis.
  • S protein mediates viral entry by attaching to cellular receptors.

Conclusions:

  • No definitive cure for COVID-19 exists; drug repurposing is underway.
  • Comprehensive studies on viral genomics and host cell interactions are essential for developing treatments.

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
535
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
8.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K